Castle Biosciences Inc
General ticker "CSTL" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $827.0M
Castle Biosciences Inc follows the US Stock Market performance with the rate: 50.2%.
Estimated limits based on current volatility of 2.5%: low 26.47$, high 27.81$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [14.99$, 32.52$]
- 2024-12-30 to 2025-12-30 estimated range: [14.27$, 30.94$]
Financial Metrics affecting the CSTL estimates:
- Negative: Non-GAAP EPS, $ of -2.16 <= 0.10
- Negative: Operating profit margin, % of -23.62 <= 1.03
- Negative: Operating cash flow per share per price, % of -1.03 <= 2.35
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0.67 <= 1.08
- Positive: -0.96 < Investing cash flow per share, $ of -0.60
Short-term CSTL quotes
Long-term CSTL plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $94.08MM | $137.04MM | $219.79MM |
| Operating Expenses | $134.16MM | $209.89MM | $287.76MM |
| Operating Income | $-40.08MM | $-72.86MM | $-67.98MM |
| Non-Operating Income | $0.07MM | $3.95MM | $10.61MM |
| Interest Expense | $0.00MM | $0.02MM | $0.01MM |
| R&D Expense | $29.65MM | $44.90MM | $53.62MM |
| Income(Loss) | $-40.01MM | $-68.90MM | $-57.37MM |
| Taxes | $-8.72MM | $-1.77MM | $0.10MM |
| Profit(Loss) | $-31.29MM | $-67.14MM | $-57.47MM |
| Stockholders Equity | $411.74MM | $399.15MM | $391.27MM |
| Inventory | $2.02MM | $3.98MM | $7.94MM |
| Assets | $462.57MM | $447.33MM | $453.34MM |
| Operating Cash Flow | $-18.98MM | $-41.66MM | $-5.63MM |
| Capital expenditure | $3.48MM | $5.63MM | $13.62MM |
| Investing Cash Flow | $-66.66MM | $-166.54MM | $-16.18MM |
| Financing Cash Flow | $5.42MM | $1.51MM | $-2.30MM |
| Earnings Per Share* | $-1.24 | $-2.58 | $-2.14 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.